These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2999952)

  • 1. Preliminary results of a short-course antituberculosis regimen including Sinerdol-EH and applied under operational conditions.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):149-55. PubMed ID: 2999952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Remote (2-3 years) results in patients with pulmonary tuberculosis treated in operational conditions in combination with sinerdol-EH].
    Păunescu E; Mihăilescu P; Fonea M; Ciocan A; Serban G; Eliescu A; Serban S; Grigorescu C; Tiţei I; Popescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(2):137-44. PubMed ID: 2825331
    [No Abstract]   [Full Text] [Related]  

  • 3. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):33-42. PubMed ID: 6312533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials, in children, of an anti-tubercular preparation. Sinerdol-EH in a potable solution].
    Fierbinţeanu O; Păunescu E; Macry V; Filimon M; Turcuş S; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):215-26. PubMed ID: 6318294
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sinerdol-EHr--a new broad-spectrum antibiotic. The results in treating tuberculosis in adults and children].
    Păunescu E; Sauciuc A
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(1):113-22. PubMed ID: 3877965
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
    Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
    [No Abstract]   [Full Text] [Related]  

  • 8. Field trial of short course chemotherapy for pulmonary tuberculosis: results at 30 months.
    Kecharananta P; Jittinandana A; Rattarasarn S; Sriyabhaya N
    J Med Assoc Thai; 1985 Jun; 68(6):283-7. PubMed ID: 4056632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed results of treatment of pulmonary tuberculosis with rifampicin].
    Fréour P; Bernadou M; Chomy P
    Gruzlica; 1974 May; 42(5):439-42. PubMed ID: 4464235
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
    Corpe R
    Bull Int Union Tuberc; 1972 Feb; 47():41-7. PubMed ID: 4562017
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 12. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
    Gomi J; Aoyagi T; Fukuhara Y; Yamaguchi T; Matsumiya T
    Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
    Eule H; Kärnbach E; Kaluza P; Herrmann H
    Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifapentine for the treatment of pulmonary tuberculosis.
    Munsiff SS; Kambili C; Ahuja SD
    Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
    Jungbluth H
    Prax Klin Pneumol; 1984 May; 38(5):177-81. PubMed ID: 6379634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 20. [Team-controlled study the effectiveness of chemotherapy with outpatients with fibrous-cavitary tuberculosis].
    Margulis NIu; Korotaev GA; Golubeva VN; Iusman ZI; Roslik SM
    Probl Tuberk; 1984 Jun; (6):6-11. PubMed ID: 6382251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.